Embolic stroke of unknown source (ESUS) in young patients

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. A100, 2015-10 ,pp. : 165-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 735-742

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II, double‐blind, randomized, parallel group, dose‐finding study of the safety and tolerability of darexaban compared with warfarin in patients with non‐valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL‐2)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1405-1413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study*

By Pratley Richard E.   Reusch Jane E.-B.   Fleck Penny R.   Wilson Craig A.   Mekki Qais  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2361-2371

Informa Healthcare

Access to resources Recommend Favorite

Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial

By Marco Ester   Duarte Esther   Vila Joan   Tejero Marta   Guillen Anna   Boza Roser   Escalada Ferran   Espadaler Josep M.  

Journal of Rehabilitation Medicine, Vol. 39, Iss. 6, 2007-07 ,pp. : 440-447

Medical Journals Limited

Access to resources Recommend Favorite